Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Conditions

• Unresectable Advanced Solid Tumors
• Biliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer

Interventions

• DRUG: Surufatinib
• DRUG: Sintilimab
• RADIATION: Short course radiotherapy

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology